iShares Russell 2000 ETF (IWM)

Small-cap stocks have historically outperformed their bigger siblings, and there are three reasons 2026 could see that trend reassert itself.

CorMedix announced that for 2026, it expects revenue between $300 million and $320 million, compared to $310 million it reported in the full year 2025, according to preliminary data.

Several Wall Street firms moved quickly to reset expectations, citing limited upside now that the stock trades close to the proposed buyout price.

The first week of 2026 has delivered a definitive verdict on the next phase of the bull market: the era of mega-cap dominance is yielding to the rise of the small-cap. In a dramatic "Great Rotation," investors are pulling capital from the expensive, AI-saturated titans of the Nasdaq and pouring

The first trading week of 2026 has delivered a powerful resurgence of the "January Effect," with small-cap stocks staging a massive rally that has outpaced their mega-cap counterparts. As of January 6, 2026, the iShares Russell 2000 ETF (NYSE:IWM) has surged an impressive 6.2%, marking one of the

The opening days of 2026 have ushered in a definitive regime shift in the global financial markets, as the long-awaited "Great Rotation" finally takes hold. After years of dominance by a handful of mega-cap technology titans, investors are aggressively reallocating capital into the small-cap sector, propelling the Russell 2000 Index

Key differences in cost, risk, and holdings shape how SPY and IWM fit into a diversified investment strategy.

Innodata operates as an AI enabler rather than a core AI platform, but is delivering strong revenue and EBITDA growth and guiding for 45%+ organic growth in 2025.